FDA Clears Avulux Migraine Lenses
FDA De Novo authorization establishes a new device classification for lenses designed to reduce migraine-associated light sensitivity
9/15/2026
2 min read
False
False
2 Topic Commentaries
FDA Clears Avulux Migraine Lenses
FDA Clears Avulux Migraine Lenses
Bradley J. Katz, MD, PhD
Neuro-ophthalmology
•John A. Moran Eye Center, University of Utah Health
Kathleen B. Digre, MD
Neuro-ophthalmology, Headache medicine
•John A. Moran Eye Center, University of Utah Health
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.